## CHD: Church & Dwight Company, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 2.4% below STRENGTH zone (3.0-6.0%); PEG 1.95 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($81.60)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Citi drops sell rating on Church & Dwight as 2026 outlook improves, valuation reflects headwinds (CHD:NYSE)**
- Source: Seeking Alpha | 20251217T130738 | Bullish | Relevance: 100%
- Citi Research has upgraded Church & Dwight (CHD) from a Sell rating, citing recent strategic actions and a 20% year-to-date retracement that better aligns the stock's valuation with its fundamentals. The improved outlook for 2026 is supported by easier comparisons, the sale of its vitamin gummy business, the acquisition of Touchland, and potential consumer trade-down to value brands, with sales acceleration and gross profit margin recovery expected.

**2. Caldwell Trust Co Invests $1.47 Million in Church & Dwight Co., Inc. $CHD**
- Source: MarketBeat | 20251216T100804 | Somewhat-Bullish | Relevance: 100%
- Caldwell Trust Co recently acquired a new stake of 15,271 shares in Church & Dwight Co., Inc. ($CHD) worth approximately $1.47 million during the second quarter. Other institutional investors have also increased their holdings in the company. Church & Dwight recently announced a quarterly dividend of $0.295 per share and reported strong Q3 earnings, beating analyst estimates.

**3. Thurston Springer Miller Herd & Titak Inc. Has $185,000 Position in Church & Dwight Co., Inc. $CHD**
- Source: MarketBeat | 20251217T142707 | Somewhat-Bullish | Relevance: 100%
- Thurston Springer Miller Herd & Titak Inc. significantly reduced its stake in Church & Dwight Co., Inc. (NYSE:CHD) by 91.8% during the third quarter, holding 2,112 shares valued at $185,000. Despite this, other hedge funds increased their positions, while institutional investors collectively own 86.60% of the company's stock. Analysts currently hold a "Hold" consensus rating for CHD with an average price target of $99.47, following mixed Q3 earnings where the company beat estimates and provided positive guidance.

**4. Citigroup Upgrades Church & Dwight to Neutral From Sell, Adjusts Price Target to $87 From $85**
- Source: marketscreener.com | 20251217T104757 | Somewhat-Bullish | Relevance: 100%
- Citigroup has upgraded Church & Dwight (CHD) from a "Sell" rating to "Neutral" and increased its price target from $85 to $87. This upgrade reflects a more positive outlook on the household products company's stock performance. Concurrently, Jefferies also upgraded Church & Dwight to "Buy" from "Hold", further indicating a growing analyst endorsement.

**5. Procter & Gamble and Church & Dwight join Jefferies' list of favorite household product stocks (PG:NYSE)**
- Source: Seeking Alpha | 20251217T085000 | Bullish | Relevance: 100%
- Jefferies has turned positive on the household and personal care products sector, adding Procter & Gamble and Church & Dwight to its list of favorite stocks. This optimistic outlook is attributed to easing macro headwinds, improved category perception, and a strong pipeline of innovations. Analyst Kaumil Gajrawala highlighted these factors in the firm's assessment.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $87 | $85 | +2% |
| 2025-12-17 | Jefferies | $102 | $97 | +5% |
| 2025-12-10 | Deutsche Bank | $100 | $102 | -2% |
| 2025-12-04 | Argus Research | $102 | $110 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | up | Neutral |
| 2025-12-17 | Jefferies | up | Buy |
| 2025-12-10 | Deutsche Bank | main | Buy |
| 2025-12-04 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 15 ($0.03M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-2.1%)
- Blackrock Inc.: 9.3% (-1.1%)
- State Street Corpora: 5.7% (+2.4%)
- JPMORGAN CHASE & CO: 5.1% (+105.9%)
- Capital Internationa: 4.0% (+0.5%)

### Key Risks

1. Long-term trend broken: trading 9.8% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.95 elevated, pricing in significant growth expectations. Forward P/E 22.7x stretched relative to 7% growth. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.7B |
| Beta | 0.45 |
| 52W Range | $81.33 - $116.46 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.95 |
| Forward P/E | 22.7 |
| Current P/E | 24.4 |
| YoY Growth | 7.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 2.4% (minimal 5-day change). Below STRENGTH zone by 0.6pp (needs >3.0% for momentum thesis). MRS_5 (-0.1%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.90x), long-term trend not supportive. RSI neutral at 52. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.38% (CS: 73) | Neutral |
| RSI_14 | 52.2 | Neutral |
| MACD Histogram | 0.35 | Bullish |
| vs SMA20 | 1.012x | Above |
| vs SMA50 | 1.000x | Below |
| vs SMA200 | 0.902x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $85.08
- **Stop Loss:** $81.60 (4.1% risk)
- **Target:** $88.56 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 204
- **Position Value:** $17,356.32
- **Portfolio %:** 17.36%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-01-30 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.74 | $0.81 | +9.9% |
| 2025Q2 | $0.86 | $0.94 | +9.5% |
| 2025Q1 | $0.90 | $0.91 | +1.4% |
| 2024Q4 | $0.77 | $0.77 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*